The US is the world’s science superpower — but for how long?
This year’s pivotal election will shape the future of US science. Rising international competition and domestic concerns are also at play.
Related Articles
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)
Peripheral T-cell lymphomas are rare and have poorer prognoses than more common B-cell lymphomas. It is therefore appropriate to highlight the current stat
Anti-obesity drug has life-changing benefits for arthritis
Nature – Clinical-trial participants saw their knee pain abate and could engage better with activities that got them up and going.
Do stem-cell transplants increase cancer risk? Long-lived recipients offer clues
Nature – People who have received transplants for blood cancer, some more than 40 years ago, do not have high rates of potentially cancer-causing mutations.
CNS Relapse in High-Grade B-cell Lymphoma with MYC and BCL2 Rearrangements and Dark-Zone Signature-Expressing DLBCL
Key Points. CNS relapse rate in HGBCL-DH-BCL2 (6.8% at 2 years) is much lower than previously reported and is associated with clinical risk factors.DZsig r
CNS Relapse in High-Grade B-cell Lymphoma with MYC and BCL2 Rearrangements and Dark-Zone Signature-Expressing DLBCL
Key Points. CNS relapse rate in HGBCL-DH-BCL2 (6.8% at 2 years) is much lower than previously reported and is associated with clinical risk factors.DZsig r
35 Do we understand benefits and harms of medical screening? Information material focusing on informed choice, when invited to cervical cancer screening
The benefits and harms of cervical cancer screening are delicately balanced, why participation should be based on an informed choice. In the process of obtaining…
Early diagnosis and a linear view of time: a dangerous link · Cancer Rose
April 10, 2024, by Cancer Rose DOI: 10.1177/13634593241234481journals.sagepub.com/home/hea Authors of the article : Christina Sadolin Damhus, Post doc PhD , Centre of Research and Education in…
Current myeloproliferative neoplasm scoring systems for clinical practice
BCR::ABL1-negative myeloproliferative neoplasms (MPN) are clonal hematological malignancies resulting from the proliferation of myeloid cells harboring a J
Safety and efficacy of proactive versus reactive administration of desmopressin in severe symptomatic hyponatremia: a randomized controlled trial
Scientific Reports – Safety and efficacy of proactive versus reactive administration of desmopressin in severe symptomatic hyponatremia: a randomized controlled trial
